Mr. du Toit is responsible for leading Publicis Health’s global business development strategy.
Novartis hired Elizabeth Barrett, Pfizer’s head of oncology, to replace Bruno Strigini, the chief executive officer of Novartis Oncology who retired at the end of 2017.
McCann Health announced the appointment of Marcus Sigurdsson to the new position of Global Chief Digital Officer.
GlaxoSmithKline Chief Executive Officer Emma Walmsley continues to overhaul the company’s pharmaceutical division. Since assuming GSK’s helm, Walmsley has replaced about 50 of its top managers.
OvaScience is restructuring to cut costs. As part of that process, the company is laying off about half of its staff.
Expansion Therapeutics officially launched with the close of a $55.3 million Series A financing.
Intouch Solutions Advances Strategic Planning and Client Services Offerings with Leadership Promotions
Intouch Solutions, a leading marketing agency serving the pharmaceutical industry, announced several leadership promotions.
Diane Iler-Smith has returned to Biolumina as SVP, Executive Creative Director. Biolumina is a full-service, integrated agency delivering omnichannel solutions for the pharmaceutical industry
Teva Pharmaceutical Industries announced a new organization and leadership structure aimed to achieve better commercial focus and drive value creation.
W2O Group, a network of innovative analytics-driven, digital-first marketing and communications firms, announced the appointment of three senior executives in its growing Chicago office.
Omnicom Health Group announced that Mario Muredda has been named CEO of Harrison and Star and former CEO Ty Curran has been promoted to chairman. The changes are effective January 1, 2018.
Inception Companies Hires Agency Titan Matt Giegerich to Serve as New CEO for its Two Lead Businesses
The Inception Companies announced the appointment of Matt Giegerich, longtime CEO of WPP’s Ogilvy CommonHealth, to serve as CEO for Inception’s two largest business units.
NEW YORK CITY (October 5, 2017) – Intouch Solutions proudly announces the promotion of Michelle Ziekert to senior vice president, executive creative director. A leading marketing agency serving the pharmaceutical industry, Intouch has seen rapid expansion over the past five years and actively promotes experienced leaders from within the over 650-person firm. Ziekert joined Intouch […]
David Meeker, the former head of rare diseases for Sanofi Genzyme, left the company in 2017 and reappeared at the helm of gene therapy startup KSQ Therapeutics.
Kaleido Biosciences Emerges From Stealth Mode With $65 Million and Will be Helmed by Fomer Cubist Exec
Kaleido Biosciences emerged from stealth mode with an additional capital raise, hitting a total of $65 million. In addition, the company appointed Mike Bonney as chief executive officer and chairman of the board.
Purohit Navigation, a full-service healthcare communications and advertising agency, hired Brad Sherrill as Vice President of Account Services.
After six months, Teva Pharmaceutical’s search ended as the company hired a new chief executive officer.
Giant Creative/Strategy LLC hired two industry veterans: Aaron Sklar joined Giant as Vice President, Brand Experience, and Andrew Wint was appointed SVP, Technology.
Novartis CEO Joe Jimenez will step down on Feb. 1, 2018, and hand over the top leadership role of the Swiss company to drug development chief Vas Narasimhan.
PACIFIC Communications, the West Coast’s largest healthcare communications agency, announced the return of Associate Creative Director/Copy Kent Sewell.